Consumer Cyclical
Live Price
Offline$0.0314
+0.00% today
1Y Change
-29.60%
Window
Jun 20, 2025 → Jun 8, 2026
Coverage: 245 bars · Jun 20, 2025 → Jun 8, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
PT Aspirasi Hidup Indonesia Tbk (ACEHF) is a Consumer Cyclical stock with a market cap of $6.37T and listed on OTC. The stock last traded around $0.03 and down 29.6% across the available one-year price window (Jun 20, 2025 → Jun 8, 2026). Baseline metrics include revenue growth of +0.7%, EPS growth of -24.8%, a dividend yield of 9.1%. What stands out right now is revenue +0.7%, EPS -24.8%, free cash flow +142.0% with operating margin 6.5% and ROIC 5.9%. The dividend matters to the case here, with a current yield around 9.1%. Valuation is more restrained than many high-expectation growth names at P/E 9.2 and price/sales 0.7. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines ACEHF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Cyclical peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
ACEHF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
ACEHF Max Drawdown
-92.15%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for ACEHF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$6.5T
-3.2% YoY
FY Net Income
$690.8B
+4.0% YoY
Free Cash Flow
$1.2T
+138.8% YoY
Revenue Growth
+0.7%
EPS Growth
-24.8%
Gross Margin
45.5%
Net Margin
7.8%
Income statement
IDR
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 8638.7B | 8582.5B | 7611.9B | 6762.8B | 6543.4B |
| Gross Profit | 4115.1B | 4182.8B | 3427.4B | 3268.0B | 3212.6B |
| Operating Income | 623.8B | 1167.0B | 1000.3B | 876.1B | 911.4B |
| EBITDA | 1458.2B | 1669.1B | 1504.5B | 1011.8B | 1053.8B |
| Net Income | 668.7B | 892.0B | 763.5B | 664.3B | 690.8B |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
IDR
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2307.6B | 1875.1B | 2312.4B | 2108.2B | 2543.8B |
| Total Assets | 8521.6B | 8191.4B | 7753.3B | 7097.4B | 7189.8B |
| Total Liabilities | 1924.3B | 1679.1B | 1566.9B | 1312.2B | 1677.1B |
| Shareholder Equity | 6521.8B | 6475.9B | 6143.4B | 5883.8B | 5481.5B |
| Total Debt | 1070.2B | 920.2B | 875.1B | 708.3B | 834.4B |
| Net Debt | -1237.5B | -955.0B | -1437.2B | -1400.0B | -1709.5B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
1305.4B
+110.9% YoY
Capital Expenditures
84.4B
+21.4% YoY
Free Cash Flow
1221.0B
+138.8% YoY
Key ratios
Gross Margin
45.5%
Operating Margin
6.5%
Net Margin
7.8%
ROE
10.7%
Debt / Equity
0.15x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.